The broad and long-term objectives of this application focus on elucidating the role of retinoids in viral latency. Human cytomegalovirus (HCMV) is of great societal significance and has become an important cause of morbidity and mortality for individuals in the clinical setting. particularly cancer patients, neonates and AIDS patients. Latent infection of humans is a very fundamental aspect of HCMV disease which may also significantly impact on the development of a number of human malignancies. Reactivation of latent virus is believed to result from a signal transduction event that induces immediate-early (lE) gene transcription. The three specific aims described in this proposal attempt to address the direct involvement of retinoids and their cognate nuclear receptors in regulating the HCMV major lE gene by Its promoter (MIEP). The first specific aim will involve an Investigation of the expression of the HCMV- MIEP in an established transgenic mouse model system that has the MIEP linked to the lacz reporter gene. Control animals that carry a mutant MIEP-RAREs lacz reporter gene will be generated. The expression profile of the MIEP-Lacz will be compared with the expression pattern of the various retinoic acid receptors (RARs) and should indicate whether a superimposition of MIEP expression and RARs expression exists. To examine whether the MIEP can be activated tn vivo by RA, transgenic mice will be administered with exogenous doses of RA and the induction of the MIEP will be determined. The second specific aim will elucidate the mechanisms underlying retinoid induction of the MIEP in an established human embryonal carcinoma (EC) cell system shown to be non-permissive in the uninduced state but replicates HCMV alter RA induction. Experiments are designed to precisely define the MIEP RA response elements and to investigate the direct interaction of the known RARs. The third specific aim will test for the involvement of the RARs in determining HCMV permissiveness by EC cell lines expressing trans-dominant negative retinoid receptors. These EC cell lines will be analyzed for their ability to inhibit RA induced HCMV replication. These proposed experiments should increase our knowledge of elements which lead to the activation of HCMV from latency and should provide insight in alternative methods for drug therapy.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA066167-04
Application #
2443131
Study Section
Virology Study Section (VR)
Program Officer
Wong, May
Project Start
1994-09-01
Project End
1999-06-30
Budget Start
1997-07-01
Budget End
1999-06-30
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Kanakaraj, P; Ngo, K; Wu, Y et al. (1999) Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice. J Exp Med 189:1129-38
Dickinson, L A; Trauger, J W; Baird, E E et al. (1999) Anti-repression of RNA polymerase II transcription by pyrrole-imidazole polyamides. Biochemistry 38:10801-7
Chambers, J; Angulo, A; Amaratunga, D et al. (1999) DNA microarrays of the complex human cytomegalovirus genome: profiling kinetic class with drug sensitivity of viral gene expression. J Virol 73:5757-66
Lee, K J; Angulo, A; Ghazal, P et al. (1999) Soluble-polymer supported synthesis of a prostanoid library: identification of antiviral activity. Org Lett 1:1859-62
Redpath, S; Angulo, A; Gascoigne, N R et al. (1999) Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10. J Immunol 162:6701-7
Angulo, A; Chandraratna, R A; LeBlanc, J F et al. (1998) Ligand induction of retinoic acid receptors alters an acute infection by murine cytomegalovirus. J Virol 72:4589-600
Angulo, A; Messerle, M; Koszinowski, U H et al. (1998) Enhancer requirement for murine cytomegalovirus growth and genetic complementation by the human cytomegalovirus enhancer. J Virol 72:8502-9
Angulo, A; Suto, C; Heyman, R A et al. (1996) Characterization of the sequences of the human cytomegalovirus enhancer that mediate differential regulation by natural and synthetic retinoids. Mol Endocrinol 10:781-93
Baskar, J F; Smith, P P; Ciment, G S et al. (1996) Developmental analysis of the cytomegalovirus enhancer in transgenic animals. J Virol 70:3215-26